ON
← Volver al feed
La virulencia de la Antártida podría ayudar a desarrollar un nuevo medicamento contra el melanoma
XK🔬 Cienciaanteayer

La virulencia de la Antártida podría ayudar a desarrollar un nuevo medicamento contra el melanoma

A study published by researchers from the University of Florida has discovered that toxins produced by a small marine organism known as 'ascidians' or sea squirts living in Antarctica could potentially aid in developing a new treatment for melanoma, one of the deadliest forms of skin cancer. The research, reported by The Guardian, indicates that these toxins have been shown to destroy melanoma cells in laboratory tests without harming healthy cells. Professor Bill Baker, a chemistry expert involved in the study, emphasized that while this is promising, the path to an approved drug is long and requires extensive testing. He noted that recent expeditions to Antarctica provided valuable insights into how bacteria within these organisms produce the toxins, bringing scientists closer to potential treatments. However, challenges remain, including the difficulty of harvesting sufficient quantities of the toxin without damaging the Antarctic ecosystem. Baker also highlighted that over half of approved drugs originate from natural substances, underscoring the significance of such discoveries.

Ir a las fuentes primarias (1)

Las fuentes oficiales en las que se basa la cobertura. Léelas directamente para evitar el encuadre.

1 informaciones

Koha.net logoKoha.netIndependienteCentroVeracidad 85Objetividad 75anteayer
La virulencia de la Antártida podría ayudar a desarrollar un nuevo medicamento contra el melanoma

A study published by researchers from the University of Florida has discovered that toxins produced by a small marine organism known as 'ascidians' or sea squirts living in Antarctica could potentially aid in developing a new treatment for melanoma, one of the deadliest forms of skin cancer. The research, reported by The Guardian, indicates that these toxins have been shown to destroy melanoma cells in laboratory tests without harming healthy cells. Professor Bill Baker, a chemistry expert involved in the study, emphasized that while this is promising, the path to an approved drug is long and requires extensive testing. He noted that recent expeditions to Antarctica provided valuable insights into how bacteria within these organisms produce the toxins, bringing scientists closer to potential treatments. However, challenges remain, including the difficulty of harvesting sufficient quantities of the toxin without damaging the Antarctic ecosystem. Baker also highlighted that over half of approved drugs originate from natural substances, underscoring the significance of such discoveries.

Lectura del sesgo (Centro): The article presents scientific findings without overt ideological framing. It focuses on the research process, challenges, and implications of the discovery without taking a partisan stance. The tone remains objective, emphasizing the scientific method and the need for further testing rather than a

Por qué estas puntuaciones (Veracidad 85 · Objetividad 75): The article accurately reports the research findings from the primary source, including the use of ascidian toxins against melanoma in mice. However, it slightly simplifies the process and omits details about regulatory trials and the broader implications of the research. The tone is generally neutr

Mantengamos las noticias honestas.

ObjectiveNews se financia con los lectores y no tiene anuncios: te mostramos el sesgo en lugar de ocultarlo. Apoya el periodismo independiente por 5 €/mes.

Hazte suscriptor

Historias relacionadas